Interleukin-24 (IL-24), a member of the IL-10 superfamily first identified as a negative regulator of human melanoma, has demonstrated bystander antitumor effects without cytotoxic activity toward normal cells [9–11]. This evidence concerns the gene IL24 and melanoma.